CURRICULUM VITAE Anne M. Bowcock, Ph.D.

Address:
Washington University School of Medicine
Campus Box 8232
4566 Scott Ave.
St. Louis, MO 63110
Telephone - (314) 747-3264
Fax - (314) 747-2489
Email - bowcock@genetics.wustl.edu
 

Present Position:
Professor of Genetics, Pediatrics and Medicine
Joint Director Division of Human Genetics
Washington University School of Medicine
St. Louis, Missouri
 

Education:

Undergraduate:
1975 - 1978	B.Sc. Honors Degree in Genetics (First Class) University of the Witwatersrand, Johannesburg, South Africa
1979 - 1981	Research studentship with Dr. David Finnegan, Department of Molecular Biology, University of Edinburgh, Scotland
Graduate:
1981 - 1984	Ph.D. in Genetics and Human Genetics, University of the Witwatersrand, Johannesburg, South Africa. Thesis title: Identification of Restriction Fragment Length Polymorphisms in Southern African Human Populations. Principal advisors: Professors Trefor Jenkins and Jennifer Thompson
Postgraduate:
1984 - 1990	Postdoctoral Fellow, Department of Genetics, Stanford University Advisor: Professor Luca Cavalli-Sforza

Academic Position/Employment:

03/1999 - present	Professor, Depts. Genetics, Pediatrics and Medicine (1/1/00); Joint Director Division of Human Genetics, Washington University Medical Center, St. Louis, MO
09/98 - 03/1999	Associate Professor, Department Internal Medicine and Pediatrics and Eugene McDermott Center for Human Growth and Development
09/94 - 08/98	Associate Professor, Department of Pediatrics and the McDermott Center for Human Growth and Development
08/90 - 08/94	Assistant Professor, Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas, TX
02/84 - 07/90	Postdoctoral Fellow, Department of Genetics, Stanford University, California

 

Honors and Awards:

9/95	The 16th von Weiligh Lecturer, Johannesburg, South Africa
1981	Medical Research Council (South Africa) Award for international travel
1979-1981	British Petroleum Research Studentship
1978	Julius Robson Postgraduate Scholarship

 

Editorial Boards:

09/01 -	Human Genetics
01/99 -	Human Molecular Genetics
01/97 -	Genomics
01/97 -	Genome Research
08/93 - 12/94	PCR Methods and Applications
03/94 - 1997	Editor, Cytogenetics and Cell Genetics
01/95 - 12/97	Editor, American Journal of Human Genetics

Professional Societies:
2002 - Member of Faculty of 1000
1999 - The Society for Investigative Dermatology
1991 - Member of Human Genome Organization (HUGO)
1990 - The American Association for the Advancement of Science
1985 - The American Society of Human Genetics
 

Other Professional Activities:

6/03 - present	Board of Directors, American Society of Human Genetics
5/02	Panel Participant/Speaker; Colloquium on Germ line Interventions and Human Research Ethics Symposium, Washington University School of Law
6/02	Scientific Advisory Committee, International Psoriasis Community; website: www.ipsoriasis.org
1/99 - 12/99	The American Society of Human Genetics Nominating Committee
12/97	Participant, National Human Genome Research Institute Workshop on Functional Genomics
11/94 - 11/95	Member, Common Adult Diseases Subcommittee of American College of Medical Genetics
11/93 - 10/94	Chairman of ASHG genome subcommittee dealing with the diagnosis and treatment of breast cancer.
1/93 - 6/95	Member of ASHG (American Society of Human Genetics) Human Genome Committee
12/91 -	Senior editor of DNA committee for Human Gene Mapping Workshop
1/91 - 12/92	Chairman of CEPH Chromosome 15 Consortium Mapping
9/90 -	DNA Polymorphism Editor for the Genome Database, John's Hopkins University, Baltimore
12/89 -	Member of CEPH (Human Polymorphism Study Center, Paris)
7/89 - 07/91	Chair., Chromosome 13 Committee, Human Gene Mapping Workshops 10.5 and 11
7/89 - 06/91	Chairman of CEPH Chromosome 13 Linkage Map Consortium
7/87 - 07/91	Co-chair., DNA Committee, Human Gene Mapping Workshops 9.5 and 10.0, 10.5 and 11

 

Meeting/Workshop Organizer:

10/02	Co-organizer: “The new era of positional cloning“, American Society of Human Genetics, Baltimore.
4/27/02 - 4/28/02	Chairperson, 6th International Psoriasis Genetics Committee Meeting, Nice, France
10/95	Chairperson, First International Human Psoriasis Consortium meeting, Dallas, TX, 10/95.
5/94	U.S. Organizer of Second International Human Chromosome 13 Workshop, Groningen, The Netherlands.
9/20/92 - 9/23/92	Organizer of First International Human Chromosome 13 Workshop, Dallas
7/2/92 - 7/3/92	Organizer of Ad Hoc GDB Advisory Group Meeting on DNA nomenclature issues, Dallas

 

Study Sections/Grant Review:

4/02	Peer Review Member, Special Research Programs, Office of Health Affairs, University of California (Pathogenesis)
4/99	Peer Review Member, Special Research Programs, Office of Health Affairs, University of California
1/95 - 10/98	Member, N.I.H. Grant Review Committee: National Center for Human Genome Research
10/95	Peer Review Panel Member, U.S. Army Medical Research and Materiel Command: Cancer Center #1
3/95	Komen Foundation Research Fellowship National Grant Selection and Review Committee
04/93	Ad Hoc Reviewer for N.I.H. Mammalian Genetics Special Study Section
10/92 - 12/94	Ad Hoc Reviewer for N.I.H. Study Sections, National Center for Human Genome Research and Mammalian Genetics Fellowships.

 

Consulting:

04/93 - present	Geneticist and Laboratory Director of National Psoriasis Tissue Bank
07/86 - 07/87	Consultant for Focus Technologies Inc., Washington

 

Teaching Responsibilities:

2002-present	Co-organizer of “Linkage and Association“ course for Masters and Graduate students, Washington University Medical School
2002-present	Program Executive and Admissions Committee Genetic Epidemiology Master of Science, Washington University Medical School
2002	Co-organizer and lecturer in special topics for Medical Genetics (first year medical students), Washington University Medical School
2001-present	Lecturer and co-organizer: Medical Genetics for first year Medical students, Washington University Medical School
2000-present	Lecturer in Advanced Genetics (first year genetics graduate students), Washington University Medical School
2000	Organizer of and lecturer in “Genetic Foundations“ (part of Master of Science in Clinical Investigation Program: Coursemasters: F. Sessions Cole, MD, Ph.D., Steven D. Shapiro, MD).
1999 - present	Lecturer in special topics for Medical Genetics (first year medical students), Washington University Medical School
1999-present	Molecular Genetics Steering Committee, Washington University School of Medicine
6/97 - 03/99	Co-organizer of human genetics section of second year core course for Genetics and Development, University of Texas Southwestern Medical Center at Dallas, TX
10/92 - 03/99	Director of second year Human Genetics course for Genetics and Development graduate program at University of Texas Southwestern Medical Center, Dallas, TX
10/90 - 03/99	Lecturer in Human Genetics Course for first year Medical Students, University of Texas Southwestern Medical Center at Dallas, TX

 

Inventions:
1998 U.S. Patent Application entitled “Compositions and Uses Thereof in the Diagnosis of Psoriasis, Anne Bowcock, et al. Patent Number 5,811,233.
 

Bibliography:

1. Finnegan DJ, Will BM, Bayev AA, Bowcock AM, and Brown L: Transposable DNA sequences in eukaryotes, in Genome Evolution, Systematics Association, Special Volume No. 20, eds, GA Dover and RB Flavel, (1982).

2. Bowcock AM, van Tonder S, and Jenkins T: The haemoglobin H disease mental retardation syndrome: Molecular studies on the South African case. The Brit. J. Haematol. 56:69-78 (1984).

3. Bowcock AM, Pinto MR, Bey E, Kuyl JM, Dusheiko GM, and Berstein R: The PLC/PRF/5 Human hepatoma cell line. II. Chromosomal assignment of hepatitis B virus integration sites. Cancer Genet. Cytogent. 18:19-26 (1985).

4. Bowcock AM, Crandall J, Daneshvar L, Lee GM, Young B, Zunzunegui V, Craik C, Cavalli-Sforza LL, and King M-C: Genetic analysis of cystic fibrosis: Linkage of DNA and classical markers in multiplex families. Am. J. Hum. Genet. 39: 699-706 (1986).

5. Beaudet A, Bowcock AM, Buchwald M, Cavalli-Sforza L, Farrall M, King M-C, Klinger K, Lalouel J-M, Lathrop G, Naylor S, Ott J, Tsui L-C, Wainwright B, Watkins P, White R, and Williamson R: Linkage of cystic fibrosis to two tightly linked DNA markers: Joint report from a collaborative study. Am. J. Hum. Genet. 39:681-693 (1986).

6. Bowcock AM, Kavathas P, Margolskee RF, Herzenberg L, and Cavalli-Sforza LL: An RFLP associated with pcDLeu2-14, a human T-cell differentiation antigen CD8 (Leu2) mapped to 2p12. Nucl. Acids Res. 14:7817 (1986).

7. Rosendorff J, Bowcock AM, Kuyl JM, Mendelow B, Pinto MR, and Bernstein R: Localization of the human c-mos gene by in situ hybridization in 2 cases of M2-acute nonlymphocytic leukemia. Cancer Genet. Cytogenet. 24:137-141 (1987).

8. Bowcock AM, Farrer LA, Hebert JM, Bonne-Tamir B, Kidd KK, Frydman M, and Cavalli-Sforza LL: A new RFLP identified by 7D2 places D13S10 proximal to esterase D. Cytogenet. Cell Genet. 44:236-237 (1987).

9. Bowcock AM, Farrer LA, Cavalli-Sforza LL, Hebert JM, Kidd KK, Frydman M, and Bonne-Tamir B: Mapping the Wilson's disease locus to a cluster of linked polymorphic markers on chromosome 13. Am. J. Hum. Genet. 41:27-35 (1987).

10. Cavalli-Sforza LL, Kidd JR, Kidd KK, Bucci C, Bowcock AM, Hewlett BS, and Friedlaender JS: DNA markers and genetic variation in the human species. C.S.H. Quantitative Biol. 51:411-417 (1987).

11. Farrall M, Lathrop M, Spence JE, Bowcock AM, Klinger K, and Tusi L-C: Further linkage data between cystic fibrosis and 7C22 (D7S16). Am. J. Hum. Genet. 41:286-287 (1987).

12. Bowcock AM, Hebert JM, Christiano AM, Wijsman E, Cavalli-Sforza LL, and Boyd CD: The pro alpha 1 (IV) collagen gene is linked to the D13S3 locus at the distal end of human chromosome 13q. Cytogenet. Cell Genet. 45:234-236 (1987).

13. Bowcock AM, Bucci C, Hebert JM, Kidd JR, Kidd KK, Friedlaender JS, and Cavalli-Sforza LL: Study of 47 DNA markers in five populations from four continents. Gene Geog. 1:47-64 (1987).

14. Bowcock AM, Scheffer H, Hebert JM, van den Berg A, and Buys CHCM: A high frequency RFLP identified by an anonymous single copy genomic clone at 13q14.1-13q14.2 (HGM8 assignment no. D13S22), Nucl. Acids Res. 15:382 (1987).

15. Feder JN, Bowcock AM, Cavalli-Sforza, and Schimke R.T. Nucl. Acids Res. 15:5906 (1987).

16. Choi K, Hake LE, Bowcock AM, Roninson IB, and Cavalli-Sforza LL: RFLPs associated with MDR2, a member of the human multidrug resistance gene family mapped to 7q21.1. Nucl. Acids Res. 15:6306 (1987).

17. Farrer LA, Bonne-Tamir B, Frydman M, Magazanik A, Kidd KK, Bowcock AM, and Cavalli-Sforza LL: Predicting genotypes at loci for autosomal recessive disorders using linked genetic markers: Application to Wilson's disease. Hum. Genet. 79:109-117 (1988).

18. Bowcock AM, Hebert JM, Wijsman E, Gadi I, Cavalli-Sforza LL, and Boyd C: High recombination between two physically close human basement membrane collagen genes at the distal end of chromosome 13q. Proc. Natl. Acad. Sci. USA 85:2701-2705 (1988).

19. Bowcock AM, Fahnestock M, Goslin K, and Shooter EM: The NGF and Kallikrein genes of mouse, the African rat Mastomys Natalensis and man: Their distribution and mode of expression in the salivary gland. Molec. Brain Res. 3:165-172 (1988).

20. Bowcock AM, Kidd JA, Lathrop M, Daneshvar L, May LT, Ray A, Sehgal PB, Kidd KK, and Cavalli-Sforza LL: The human interferon "beta-2/hepatocyte stimulating factor/interleukin-6" gene: DNA polymorphisms and localization to chromosome 7p21. Genomics 3:8-16 (1988).

21. Bowcock AM, Hebert JM, and Cavalli-Sforza LL: Polymorphisms revealed by random probe H2-10 (D13S26) which maps to chromosome 13q21-q22. Nucl. Acids Res. 16:2745 (1988).

22. Bowcock AM, Farrer LA, Hebert JM, Agger M, Sternlieb I, Scheinberg IH, Frydman M, Chajek-Saul T, Bonne-Tamir B, and Cavalli-Sforza LL: Eight closely linked loci place the Wilson's disease locus within 13q14-q21. Am. J. Hum. Genet. 43:664-674 (1988).

23. Bowcock AM, Fulton TR, Daneshvar L, Vollrath D, Smith D, King M-C, Bowden D, Donis-Keller H, and Cavalli-Sforza LL: Long-range mapping of the cystic fibrosis gene region. In Cellular and Molecular Basis of Cystic Fibrosis, G Mastella and P Quinton (eds), San Francisco Press, pp. 65-72 (1988).

24. Kidd KK, Bowcock AM, Pearson PL, Schmidtke J, Willard HF, Track RK, and Ricciuti F: Report of the committee on human gene mapping by recombinant DNA techniques. Human Gene Mapping 9.5: Update to the 9th International Workshop on Human Gene Mapping. Cytogenet. Cell Genet. 49:132-218 (1988).

25. Kitzis A, Chomel JC. Haliassos A. (Many authors including A.M. Bowcock). Unusual segregation of cystic fibrosis alleles. Nature 336:316 (1988).

26. Fulton TR, Bowcock AM, Smith DR, Daneshvar L, Green P, Cavalli-Sforza LL, and Donis-Keller H: A 12 megabase restriction map at the cystic fibrosis locus. Nucl. Acids Res. 17:271-284 (1989).

27. Bowcock AM, Farrer LA, Hebert JM, Agger M, Sternlieb I, Scheinberg IH, Buys CHCM, Scheffer H, Frydman M, Chajek-Saul T, Bonne-Tamir B, and Cavalli-Sforza LL: DNA markers at 13q14-q22 linked to Wilson's disease, in Molecular Probes, Technology and Medical Applications, Albertini A, Paoletti R, and Reisfeld R (eds), pp. 51-60 (1989).

28. Bowcock AM, Ray A, Erlich HA, and Sehgal PB: The molecular genetics of beta-2 interferon/interleukin 6. In Regulation of the Acute Phase and Immune Responses: Interleukin-6, PB Sehgal PB, Grieninger G, and Tosato G (eds), Annals of the New York Academy of Sciences 557:345-352 (1989).

29. Smith DR, Fulton TR, Swain P, Bowcock AM, Daneshvar L, Traver C, Gruenert DC, Davis R, Cavalli-Sforza LL, and Donis-Keller H: Cystic Fibrosis: Diagnostic testing and the search for the gene. Clin. Chem. 35:B17-B20 (1989).

30. Kidd KK, Bowcock AM, Schmidtke J, Track R, Ricciuti F, Hutchings G, Bale A, Pearson P, and Willard HF: Report of the committee on human gene mapping by recombinant DNA techniques. Human Gene Mapping 10 (1989): The 10th International Workshop on Human Gene Mapping. Cytogent. Cell Genet. 51:67-90.

31. Stewart EA, Kopito R, and Bowcock AM: A PstI polymorphism for the human erythrocyte surface protein band 3 (EPB3), demonstrates close linkage of EPB3 to the nerve growth factor receptor. Genomics 5:633-635 (1989).

32. Bowcock AM, Anuradha R, Erlich H, and Sehgal PB: Rapid detection and sequencing of alleles in the 3' flanking region of the interleukin-6 gene. Nucl. Acids Res. 17:6855-6864 (1989).

33. Bowcock AM and Hebert JM: The anonymous DNA probe p7-26 identifying the locus D17S17, reveals an XmnI polymorphism. Nucl. Acids Res. 17:1787 (1989).

34. Bowcock AM, Hebert JM, Scheffer, Penninga D, Cavalli-Sforza LL, and Buys CHCM: The single copy probe pG24E2.4 (D13S21) reveals a Bsp1286 RFLP at 13q14.1-q14.2. Nucl. Acids Res. 17:8398 (1989).

35. Bowcock AM, Hebert JM, Scheffer H, Penninga D, Cavalli-Sforza LL, and Buys CHCM: The single copy probe pG50 (D13S24) reveals an SspI RFLP at 13q22-qter. Nucl. Acids Res. 17:8399 (1989).

36. Bowcock AM and Hebert JM: The alpha chain of human propionyl CoA carboxylase (PCCA) (mapped to chromosome 13) detects and RFLP with XmnI. Nucl. Acids Res. 17:8400 (1989).

37. Bowcock AM and Hebert JM: The anonymous probe pF5a identifying the locus D13S61 detects RFLPs with XmnI and BanII. Nucl. Acids Res. 17:8397 (1989).

38. Bowcock AM and Hebert JM: The anonymous probe pR1-4 which identifies the locus D13S59 detects a BanII RFLP. Nucl. Acids Res. 17:8396 (1989).

39. Shannon KM, Turhan AG, Chang SSY, Bowcock AM, Rogers PCJ, Carroll WL, Cowan MJ, Glader BE, Eaves CJ, Eaves AC, and Kan YW: Familial bone marrow monosomy 7: Evidence that the predisposing locus is not on the long arm of chromosome 7. J. Clin. Invest. 84:984-989 (1989).

40. Merimee TJ, hewlett BS, Wood W, Bowcock AM and Cavalli-Sforza LL: The growth hormone receptor gene in the African pygmy. Trans. Assoc. Am. Physicians 102:163-169 (1989).

41. Bowcock AM, Hall J, Hebert JM, and King MC: Exclusion of the retinoblastoma gene and chromosome 13q as the primary lesion for familial breast cancer. Am. J. Hum. Genet. 46:12-17 (1990).

42. Bowcock AM and Hebert JM: An SspI RFLP at the D13S25 locus identified by the anonymous single copy probe H2-42. Nucl. Acids Res. 18:7194 (1990).

43. Kidd KK, Track RK, Bowcock AM, Ricciuti F, Hutchings G, Chan HS: Human DNA restriction fragment length polymorphisms (RFLPs). In Genetic Maps 5th Ed. O'Brien SJ (ed). Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, pp 5.211-5.245 (1990).

44. Bowcock AM and Taggart RT: Report of the committee on the genetic constitution of chromosome 13. Human Gene Mapping 10.5:177 (1990):Update to the Tenth International Workshop on Human Gene Mapping. Cytogenet. Cell Genet. 55:177-182 (1990).

45. Williamson R, Bowcock AM, Kidd K, Pearson P, Schmidtke J, Chan HS etal: Report of the DNA committee and catalogues of cloned and mapped genes and DNA polymorphism. Human Gene Mapping 10.5 (1990): Update of the Tenth International Workshop on Human Gene Mapping. Cytogenet. Cell Genet. 55:457-778 (1990)

46. Stewart EA, Craik CS, Hake L, and Bowcock AM: Human carboxypeptidase a identifies a BglII RFLP and maps to 7q31-qter. Am. J. Hum. Genet. 46:795-800 (1990).

47. Bonne-Tamir B, Frydman M, Agger MS, Becker R, Bowcock AM, Hebert JM, Cavalli-Sforza LL, and Farrer LA: Wilson's disease in Israel: A genetic and epidemiological study. Ann. Genet. 54:155-168 (1990).

48. Warren AC, Bowcock AM, Farrer LA, and Antonarakis SE: An alpha satellite DNA polymorphism specific for the centromeric region of chromosome 13. Genomics 7:110-114 (1990).

49. Bowcock AM and Sartorelli V: Polymorphism and mapping of the IGF1 gene, and absence of association with stature among African Pygmies. Hum. Genet. 85:349-354 (1990).

50. The Cystic Fibrosis Genetic Analysis Consortium. (Many authors including Bowcock AM). Worldwide survey of the _F508 mutation-report from the cystic fibrosis genetic analysis consortium. Am. J. Hum. Genet. 47:354-359 (1990).

51. Kurth JH and Bowcock AM. Rapid screening of bacterial colonies with PCR: PCR Amplifications 5:18-19 (1990).

52. Hseih C-L, Bowcock AM, Farrer LA, Hebert JM, Huang KN, Cavalli-Sforza LL, Julius D, and Francke U: The serotonin receptor subtype 2 locus HTR2 is on human chromosome 13 near genes for esterase D and retinoblastoma-1 and on mouse chromosome 14. Somat. Cell Molec. Genet. 16:567-574 (1990).

53. Bowcock AM, Kidd JR, Mountain JL, Hebert JM, Carotenuto L, Kidd KK, and Cavalli-Sforza LL: Drift, admixture, and selection in human evolution: A study with DNA polymorphisms. Proc. Natl. Acad. Sci., USA, 88:839-843 (1991).

54. Titenko NV, Kurth JH, Bowcock AM, and Cavalli-Sforza LL: Polymerase chain reaction polymorphisms in HLA-DQa and IL6 from Mongoloid and Causasoid populations. Biomed. Sci. 2:175-179 (1991).

55. Bowcock AM and Taggart RT: Report of the committee on the genetic constitution of chromosome 13. HGM 11 (1991): The Eleventh International Workshop on Human Gene Mapping. Cytogenet. Cell Genet. 58:580-604 (1991).

56. Williamson R, Bowcock AM, Kidd K, Pearson P, Schmidtke J, Ceverha P, Chipperfield M, Cooper DN, Coutelle C, Hewitt J, Klinger K, Langley K, Beckmann J, Tolley M and Maidak B: Report of the DNA committee and catalogues of cloned and mapped genes, markers formatted for PCR and DNA polymorphisms. Cytogenet. Cell Genet. 58:1190-1832 (1991).

57. Bowcock AM, Hebert JM, Mountain JL, Kidd JR, Rogers J, Kidd KK, and Cavalli-Sforza LL: Study of an additional 58 DNA markers in five human populations from four continents. Gene Geog. 5:151-173 (1991)

58. Bowcock AM. DNA markers as diagnostic tools. In Encyclopedia of Human Biology. (Renato Dulbecco, Ed) Vol. 3, pp. 135-150. Academic Press, LaJolla, CA. (1991).

59. Kurth JH, Bowcock AM, Erlich HA, Nevo S, and Cavalli-Sforza LL: Km typing with PCR: Application to population screening. Am. J. Hum. Genet. 48:613-620 (1991).

60. Farrer LA, Bowcock AM, Hebert JM, Bonne-Tamir B, Sternlieb I, Giagheddu M, St. George-Hyslop P, Frydman M, Lobner J, Demelia L, Carcassi C, Lee R, Bekker R, Bale AE, Donis-Keller H, Scheinberg IH, and Cavalli-Sforza LL: Predictive testing for Wilson's disease using tightly linked and flanking DNA markers. Neurology 41:992-999 (1991).

61. Spurr NK, Kelsell D, Rooke L, Cavalli-Sforza LL, Bowcock AM, and Feder J: Assignment of eight human genomic DNA sequences detecting high frequency restriction fragment length polymorphisms. Ann. Hum. Genet. 55:141-150 (1991).

62. Cogen PH, Daneshvar L, Bowcock AM, Metzger AK, and Cavalli-Sforza LL: Loss of heterozygosity for chromosome 22 DNA sequences in human meningioma. Cancer Genet. Cytogenet . 53:271-277 (1991).

63. Bowcock AM and Cavalli-Sforza: The study of variation in the Human Genome. Genomics 11:491-498 (1991).

64. Waber PG, Bowcock AM, Arencibia-Mireles O, and Nisen PD: Nonrandom distribution of N-myc oncogene genotypes in neuroblastoma. JNCI Reports 83:1085-1088 (1991).

65. Bowcock AM, Farrer LA, Hebert JM, Bale AE, and Cavalli-Sforza LL: A contiguous linkage map of chromosome 13q with 39 distinct loci separated on average by 5.1 centimorgans. Genomics 11:517-529 (1991).

66. Albritton LM, Bowcock AM, Eddy RL, Morton C, Tseng Lena, Farrer LA, Cavalli-Sforza LL, Shows TB, and Cunningham JM: The human cationic amino acid transporter (ATRC1): Physical and genetic mapping to 13q12-q14. Genomics 12:430-434 (1992).

67. Azuma T, Liu W, Vander Laan DJ, Bowcock AM, and Taggart RT: Human Gastric Cathepsin E Gene: Multiple transcripts result from alternative polyadenylation of the primary transcripts of a single gene locus. J. Biol. Chem. 267:1609-1614 (1992).

68. Bowcock AM, Osborne-Lawrence SL, Barnes R, Weiss L, and Dunn G: Dinucleotide repeat polymorphism at the D6S223 locus. Hum. Mol. Genet. 1:66 (1992).

69. Bowcock AM, Osborne-Lawrence SL, Barnes R, Weiss L and Dunn G: Dinucleotide repeat polymorphism at the D1S167 locus. Hum. Mol. Genet. 1:138 (1992).

70. Scharf SJ, Bowcock AM, McClure G, Klitz W, Yandell D, and Erlich HA: Amplification and Characterization of the Retinoblastoma Gene VNTR by PCR. Am. J. Hum. Genet. 50:371-381 (1992).

71. Kurth JH, Bowcock AM, Erlich HA, and Cavalli-Sforza LL. HLA-DQa allelic frequencies detected with PCR in a variety of human populations. Gene Geog. 6:175-183 (1992).

72. Mountain JL, Lin AA, Bowcock AM, and Cavalli-Sforza LL. Evolution of modern humans: evidence from nuclear DNA polymorphisms. Phil. Trans. R. Soc. Lond. B 337:159-165 (1992)

73. Bowcock AM, "The Human Genome Project and Clinical Medicine" Oncology 6:71-75 (1992).

74. Bowcock AM, Azuma T, Barnes RI, Wu SH, Bell GI and Taggart RT: Detection of a polymorphism within the pepsinogen C gene with PCR: construction of a linkage map around PGC from 6p11 - 6p21.3. Genomics 14:398-402 (1992).

75. NIH/CEPH Collaborative Mapping Group (includes A. Bowcock): A Comprehensive Genetic Linkage Map of the Human Genome" Science 258:67-86 (1992).

76. Bowcock AM, Barnes RI, Weiss LE, Tomfohrde J, Dracopoli NC, Hudson T, Kruse TA, Sarfarazi M, Tsipouras P, Jenkins T, and Bergnaud G. Chromosome 15. In "A Comprehensive Genetic Linkage Map of the Human Genome" (NIH/CEPH Collaborative Mapping Group). Science 258:67-86 (1992).

77. Bowcock AM, Barnes RI, White RL, Kruse TA, Tsipouras P, Sarfarazi M, Jenkins T, Viljoen C, Litt M, Kramer PL, and Vergnaud G: The CEPH consortium linkage map of human chromosome 15q. Genomics 14:833-840 (1992).

78. Othmane KB, Hamida MB, Pericak-Vance MA, Hamida CB, Blel S, Carter SC, Bowcock AM, Petruhkin K, Gilliam TC, Roses DR, Hentati F, and Vance JM: Linkage of Tunisian autosomal recessive Duchenne-like Muscular Dystrophy to the pericentromeric region of chromosome 13q. Nature New Genetics 2:315-317 (1992).

79. Bowcock AM, Osborne-Lawrence S, Barnes R, Chakravarti A, Washington S, and Dunn C: Microsatellite Polymorphism Linkage Map of Human Chromosome 13q. Genomics 15:376-386 (1993).

80. Bowcock AM: Report of the First International Workshop on Human Chromosome 13 Mapping 1992. Cytogenetic Cell Genetics 62:89-107 (1993).

81. Harris BD, Kurth JH, Barnes RI, Bowcock AM and Kurth MC. Linkage analysis of themonoamine A and B genes using newly-defined polymorphisms. Cytogenet. Cell Genet. 62:236-237 (1993).

82. Bowcock AM, Anderson LA, Black DM, Osborne-Lawrence S, Hall JM and King M-C: THRA1 and D17S183 Flank a Interval of <4cM for the Breast-Ovarian Cancer Gene (BRCA1) on Chromosome 17q21. Am. J. Hum. Genet. 52:718-722 (1993).

83. Bowcock AM, Gerken S, Barnes RI, Shiang R, Jabs EW, Warren AC, Antonarakis S, Retief AE, and Vergnaud G. The CEPH Consortium Linkage Map of Human Chromosome 13. Genomics 16:486-496 (1993).

84. Anderson LA, Friedman L, Osborne-Lawrence S, Lynch E, Weissenbach J, Bowcock AM, and King M-C. High-density Genetic Map of the BRCA1 Region of Chromosome 17q12-21. Genomics 17:618-623 (1993).

85. Thierfelder L, MacRae C, Watkins H, Tomfohrde J, Williams M, McKenna W, Bohm K, Noeske Schlepper M, Bowcock AM, Vosberg H-P, Seidman JG, and Siedman C. A Familial Hypertrophic Cardiomyopathy Locus Maps to Chromosome 15q2. Proc. Natl. Acad. Sci. USA 90:6270-6274 (1993).

86. Stewart EA, White A, Tomfohrde J, Osborne-Lawrence S, Prestridge L, Bonne-Tamir B, Scheinberg IH, St. George-Hyslop P, Giagheddu M, Kim JW, Lo WH-y, Ivanova-Smolenskaya I, Limborska S, Cavalli-Sforza LL, Farrer LA, and Bowcock AM. Polymorphic Microsatellites and Wilson disease (WD). Am. J. Hum. Genet. 53:864-873 (1993).

87. White A, Tomfohrde J, Stewart E, Barnes R, Le Paslier D, Weissenbach J, Cavalli-Sforza L, Farrer L, and Bowcock AM. A 4.5 megabase yeast artificial chromosome contig from human chromosome 13q14.3 ordering 9 polymorphic microsatellites (22 STSs) tightly linked to the Wilson's disease locus. Proc. Natl. Acad. Sci. USA 90:10105-10109 (1993).

88. Washington SS, Bowcock AM, Gerkin S, Matsunami N, Lesh D, Cowell J, Ledbetter DH, White RL, and Chakravarti A. A Somatic Cell Hybrid Map of Human Chromosome 13. Genomics 18:486-495 (1993).

89. Chandrasekharappa SC, King SE, Freedman ML, Hayes ST, Bowcock AM, and Collins FS. The CA Repeat Marker D17S791 Is Located within 40 kb of the WNT3 Gene on Chromosome 17q. Genomics 18:728-729 (1993).

90. Bowcock AM. Molecular cloning of BRCA1: A gene for early onset familial breast and ovarian cancer". Breast Cancer Res. & Treat. 28:121-135 (1993).

91. Beckmann JS, Tomfohrde J, Barnes RI, Williams M, Broux O, Richard I, Weissenbach J, and Bowcock AM. A linkage map of human chromosome 15 with an average resolution of 2 cM and containing 54 polymorphic microsatellites. Hum. Mol. Genet. 2:2019-2030 (1993).

92. Bowcock AM, Tomfohrde J, Weissenbach J, Bonne-Tamir B, St. George-Hyslop P, Giagheddu M, Cavalli-Sforza LL, and Farrer LA. Refining the position of Wilson disease by linkage disequilibrium with polymorphic microsatellites. Am. J. Hum. Genet. 54:79-87 (1994).

93. Levedakou EN, He M, Baptist EW, Craven RN, Cance WG, Welcsh PL, Simmons A, Naylor SL, Leach RJ, Lewis TB, Bowcock AM, and Liu E. Two novel human serine/threonine kinases with homology to the cell cycle regulating Xenopus MO15, and NIMA kinases: cloning and characterization of their expression pattern. Oncogene 9:1977-1988 (1994).

94. Chandrasekharappa SC, Friedman L, King SE, Lee Y-H, Welcsh P, Bowcock AM, Weber BL, King M-C, and Collins FS: The gene for pancreatic polypeptide (PPY) and the anonymous marker D17S78 are within 45 kb of each other on chromosome 17q21. Genomics 21:458-460 (1994).

95. Bowcock AM, Ruiz-Linares A, Tomfohrde J, Minch E, Kidd JR, and Cavalli-Sforza LL. "High resolution of human evolutionary trees with polymorphic microsatellites despite a constraint in allele length. Nature 368:455-457 (1994).

96. Silverman AK, Menter A, Nemunaitis JJ, and Bowcock AM. Mapping Genes for Psoriasis. Review of a Unique Cooperative Undertaking by the Baylor Psoriasis Center, The University of Texas Southwestern Medical Center at Dallas, and the National Psoriasis Tissue Bank, BUMC Proceedings 7:13-20 (1994).

97. Orth K, Hung J, Gazdar A, Mathis M, Bowcock AM, and Sambrook J. Ovarian tumors display persistent microsatellite instability caused by mutation in the mismatch repair gene hMSH-2. C.S.H. Symposia on Quantitative Biology. 59:349-56 (1994)

98. Tomfohrde J, Silverman A, Barnes R, Fernandez-Vina MA, Young M, Lory D, Morris L, Wuepper KD, Stastny P, Menter A, and Bowcock AM. Gene for familial psoriasis susceptibility mapped to the distal end of human chromosome 17q. Science 264:1141-1145 (1994).

99. Orth K, Hung J, Gazdar A, Bowcock AM, Mathis, JM, and Sambrook J. Genetic Instability In Human Ovarian Cancer Cell Lines. Proc. Natl. Acad. Sci. USA 91:9495-9499 (1994).

100. Bowcock AM. (Chair) Statement of the American Society of Human Genetics on Genetic Testing for Breast and Ovarian Cancer Predisposition. Am. J. Hum. Genet. 55:i-iv (1994).

101. Bergstein I, Schultz R, Osborne MP, Welcsh PL, Bowcock AM, and Brown AM. Investigation of the possible role of WNT genes in human breast cancer. Ann. N. Y. Acad. Sci. 768:257 (1995). †

102. Osborne-Lawrence S, Welcsh P, Spillman M, Gallardo TD, Lovett M and Bowcock AM. Direct selection of expressed sequences within a 1 MB region flanking BRCA1 on human chromosome 17q21. Genomics 25:248-255 (1995).

103. Couch FJ, Castilla LH, Xu J, Abel KJ, Welcsh P, King SE, Wong L, Ho PP, Merajver S, Brody LC, Yin GY, Hayes ST, Gieser LM, Flejter WL, Glover TW, Friedman LS, Lynch ED, Meza JE, King, M-C, Law DJ, Deaven L, Bowcock AM, Collins FS, Weber BL, and Chandrasekharappa SC. A YAC-, P1-, and Cosmid-Based Physical Map of the BRCA1 Region on Chromosome 17q21. Genomics 25:264-273 (1995).

104. Bowcock AM. Genetic Locus for psoriasis identified. Ann. Med. 27:183-186 (1995).

105. Bowcock AM, Chipperfield M, Ceverha P, Yetman E, and Phung A. Report of the DNA committee. In Human Gene Mapping (a compendium), The Johns Hopkins University Press, Baltimore and London, pp. 1454-1768 (1995).

106. Fischer SG, Cayanis E, Bonaldo MdF, Bowcock AM, Deaven LL, Edelman IS, Gallardo T, Kalachikov S, Lawton L, Longmire JL, Lovett M, Osborne-Lawrence S, Rothstein R, Russo JJ, Soares MB, Sunjevaric I, Vendatraj VS, Warburton D, Zhang P, and Efstratiadis A. A high-resolution annotated physical map of the human chromosome 13q12-13 region containing the breast cancer susceptibility locus BRCA2. Proc. Natl. Acad. Sci. USA 93:690-694 (1996).

107. Hammani K, Blakis A, Morsette D, Bowcock AM, Schmutte C, Henriet P, and DeClerck YA. Structure and characterization of the human tissue inhibitor of metalloproteinases-2 gene. J. Biol. Chem. 271:25498-25505 (1996).

108. Abel KJ, Brody LC, Valdes JM, Erdos MR, McKinley DR, Castilla LH, Merajver SD, Couch FJ, Friedman LS, Ostermeyer EA, Lynch ED, King M-C, Welcsh PL, Osborne-Lawrence S, Spillman M, Bowcock AM, Collins FS, and Weber BL. Characterization of EZH1, a human homolog of drosophila enhancer of zeste near BRCA1. Genomics 37:161-171 (1996).

109. Spillman MA and Bowcock AM. BRCA1 and BRCA2 mRNA levels are coordinately elevated in human breast cancer cells in response to estrogen. Oncogene 13:1639-1645 (1996).

110. Wu LC, Wang ZW, Tsan JT, Spillman MA, Phung A, Xu XL, Yang M-C, Hwang L-Y, Bowcock AM and Baer R. Identification of a RING protein that interacts in vivo with the BRCA1 gene product. Nat. Genet. 14:430-440 (1996).

111. Kirkpatrick H, Waber P, Hoa-Thai T, Barnes R, Truelson J, Nisen P, and Bowcock AM. Infrequency of BRCA2 alterations in head and neck squamous cell carcinoma. Oncogene 14:2189-2193 (1997).

112. Krainer M, Silva-Arrieta S, FitzGerald MG, MacDonald DJ, Unsal H, Finkelstein DM, Bowcock AM, Isselbacher KJ, and Haber DA. Differential contributions of BRCA1 and BRCA2 to early-onset breast cancer. N. Eng. J. Med. 336:1416-1421 (1997).

113. Hoffman SMG, Lai KS, Tomfohrde J, Bowcock AM, and Gordon LA, Mohrenweiser HW. JAK3 maps to human chromosome 19p12 within a cluster of proto-oncogenes and transcription factors. Genomics 43:109-111 (1997).

114. Bowcock AM. Breast cancer genes. The Breast Journal. (Supplement) 3:1-6 (1997).

115. Barcellos LF, Klitz W, Bowcock AM, Wilson R, Tobias R, Field L, and Thomson G. Association mapping of disease loci using a pooled DNA genomic screening strategy. Am. J. Hum. Genet. 61:734-747 (1997).

116. Jin Y, Xu SL, Yang M-C W, Wei F, Ayi TC, Bowcock AM, and Baer R. Cell cycle-dependent colocalization of BARD1 and BRCA1 in discrete nuclear domains. Proc. Natl. Acad. Sci. USA 94:12075-12080 (1997).

117. Bergstein I, Eisenberg LM, Bhalerao J, Jenkins NA, Copeland NG, Osborne MP, Bowcock AM, and Brown AMC. Isolation of two novel WNT genes, WNT14 and WNT15, one of which (WNT15) is closely linked to WNT3 on human chromosome 17q21. Genomics 46:450-458 (1997).

118. Peters JM, Barnes R, Bennett L, Gitomer WM, Bowcock AM, and Garg A. Localization of the gene for familial partial lipodystrophy (Dunnigan variety) to chromosome 1q21-22. Nat. Genet. 18:292-295 (1998).

119. Thai TH, Du F, Tsou Tsan J, Jin Y, Phung A, Spillman MA, Massa HF, Muller CY, Ashfaq R, Mathis JM, Miller DS, Trask BJ, Baer R, and Bowcock AM. BARD1 (BRCA1-associated RING domain) gene alterations in breast, ovarian and uterine cancer. Hum. Mol. Genet. 7:195-202 (1998).

120. Bennett LB, Shriver MD, and Bowcock AM. Markers and Methods for Reconstructing Modern human History. DNA Sequence, J. Sequencing & Mapping 8(5):329-341 (1998).

121. Bhalerao J, Silverman A, Menter A, and Bowcock AM. Genes in Psoriasis. Psoriasis. Edited by Henry H. Roenigk, Jr. and Howard I. Maibach. Third Edition pp. 177-188 (1998).

122. Bhalerao J, and Bowcock AM. The genetics of psoriasis: a complex disorder of the skin and immune system. Hum. Mol. Genet. 7:1537-1545 (1998).

123. Yu, X, Wu LC, Bowcock AM, Aronheim A, and Baer R. The carboxy-terminal (BRCT) motifs of BRCA1 interact in vivo with CtIP, a protein implicated in the CtBP pathway of transcriptional repression. J. Biol. Chem. 273:35388-35392 (1998).

124. Ayi T-C, Tsan JT, Hwang L-Y, Bowcock AM, and Baer R. Conservation of function and primary structure in the BRCA1-associated RING domain (BARD1) protein. Oncogene 17:2143-2148 (1998).

125. Bennett LB, Taurog J, and Bowcock AM. Hereditary breast cancer genes. in Breast Cancer: Molecular Genetics, Patholgenesis, and Therapeutics. A. Bowcock (Editor). Humana Press, New Jersey. Pg 199-224, 1999.

126. Breast Cancer: Molecular Genetics, Pathogenesis, and Therapeutics in “Contemporary Approaches to Cancer Series“. A. Bowcock (Editor) Humana Press, Totowa, New Jersey (1999).

127. Steeves TDL, King DP, Zhao Y, Sangoram A, Du F, Bowcock AM, Moore RY, and Takahashi JS. Molecular Cloning and Characterization of the Human CLOCK Gene: Expression in the Suprachiasmatic Nucleus. Genomics 57:189-200 (1999).

128. Queimado, L, Lopes C, Du F, Martins C, Fonseca I, Soares J, Bowcock AM, and Lovett M. Pleomorphic adenoma gene 1 is expressed in cultured benign and malignant salivary gland tumor cells. Lab. Invest. 79:583-589 (1999).

129. Moran, JL, Johnston SH, Rauskolb C, Bhalerao J, Bowcock AM, and Vogt TF. Genomic structure, mapping and expression analysis of the mammalian Manic, Radical, and Lunatic Fringe genes. Mamm. Genome 10:535-541 (1999).

130. Queimado, L, Lopes C, Du F, Martins C, Fonseca I, Bowcock AM, Soares J, and Lovett M. In vitro transformation of cell lines from human salivary gland tumors. Intl. J. Cancer 81:793-798 (1999).

131. Garg, A, Wilson R, Barnes R, Arioglu E, Zaide Z, Gurakan F, Kocak N, O'Rahilly S, Taylor SI, Patel SB, and Bowcock AM. A gene for congenital generalized lipodystrophy maps to human chromosome 9q34. J Clin Endocrinol Metab 84:3390-3394 (1999).

132. Bennett, LB, Roach ES, and Bowcock AM. A locus for paroxysmal kinesigenic dyskinesia maps to human chromosome 16. Neurology 54:125-130 (2000).

133. Zhivotovsky, LA, Bennett L, Bowcock AM, and Feldman MW. Human population expansion and microsatellite variation. Mol. Biol. & Evol. 17:757-767 (2000).

134. Speckman, RA, Garg A, Du F, Bennett L, Veile R, Arioglu E, Shmidt HH-J, Taylor SI, Lovett M, and Bowcock AM. Mutational and haplotype analyses in familes with familial partial lipodystrophy (Dunnigan variety) reveal recurrent mis-sense mutations in the globular C-terminal domain of Lamin A/C. Am. J. Hum. Genet. 66:1192-1198 (2000).

135. Wise CA, Barnes RB, Gillum J, Herring JA, Bowcock AM, and Lovett M. Localization of susceptibility to familial idiopathic scoliosis. Spine 25:2372-2380 (2000).

136. Wise CA, Bennett LB, Pascual V, Gillum JD, Bowcock AM. Localization of a gene for familial recurrent arthritis. Arthritis & Rheum. 43:2041-2045 (2000).

137. Chatila TA, Blaeser F, Ho N, Lederman HM, Voulgaropoulos C, Helms C, and Bowcock AM. JM2, encoding a fork head-related protein, is mutated in X-linked autoimmunity-allergic disregulation syndrome. J. Clin. Invest. 106:R75-R81 (2000).

138. Swoboda, KJ, Soong BW, McKenna C, Brunt ERP, Litt M, Bale JF, Ashizawa T, Bennett LB, Bowcock, AM, Roach ES, Gerson D, Matsuura T, Heydemann PT, Nespeca MP, Jankovic J, Leppert M, and Ptacek LJ. Paroxysmal kinesigenic dyskinesia and infantile convulsions. Clinical and linkage studies. Neurology 55:224-230 (2000).

139. Bennett LB, Bowcock AM, and Roach ES. Locus for paroxysmal kinesigenic dyskinesia maps to human chromosome 16. Neurology 54:125-130, (2000).

140. Garg, A, Vinaitheerthan M, Weatherall PT, and Bowcock AM. Phenotypic heterogeneity in patients with familial partial lipodystrophy (Dunnigan variety) related to the site of mis-sense mutations in Lamin A/C (LMNA) gene. J. Clin. Endocrin. & Metabolism, 86:59-65 (2001).

141. Xu, XL, Wu LC, Du F, Davis A, Peyton M, Tomizawa Y, Maitra A, Tomlinson G, Gazdar AF, Weissman BE, Bowcock AM, Baer R, and Minna JD. Inactivation of human SRBC, located within the 11p15.5-p15.4 tumor suppressor region, in breast and lung cancers. Cancer Res. 61:7943-7949 (2001).

142. Swoboda, KJ, Soong BW, McKenna C, Brunt ER, Litt M, Bale JF Jr, Ashizawa T, Bennett LB, Bowcock AM, Roach ES, Gerson D, Matsuura T, Heydemann PT, Nespeca MP, Jankovic J, Leppert M, and Ptacek LJ. Paroxysmal kinesigenic dyskinesia and infantile convulsions. Clinical and linkage studies. 2000. Neurology 57:S42-S48 (2001).

143. Bowcock AM, and Lovett M. Zeroing in on tolerance. Nat. Med. 7:279-281 (2001).

144. Bowcock AM, Shannon W, Du F, Duncan J, Kai C, Aftergut K, Catier J, Fernandez-Vina M, and Menter A. Insights into psoriasis and other inflammatory diseases from large-scale gene expression studies. Hum. Mol. Genet. 10:1793-1805 (2001).

145. Du F, Mahadevappa M, Warrington JA, and Bowcock, AM. Gene expression changes in endometrial cancer. In “Microarrays and Cancer“, Eds. Warrington JA, Wong D, and Todd R. Eaton Publishing, pp 113-125 (2002).

146. Agarwal AK, Arioglu E, de Almeida S, Akkoc N, Taylor SI, Bowcock AM, Barnes RI, and Garg A. AGPAT2 is mutated in congenital generalized lipodystrophy linked to chromosome 9q34. Nat. Genet. 31:21-23, (2002).

147. Garg A, Speckman RA, and Bowcock AM. Multisystem dystrophy syndrome due to novel missense mutations in the amino-terminal head and alpha-helical rod domains of the lamin A/C gene. Am. J. Med. 112:549-555, (2002).

148. Speckman RA, Daw J, Helms C, Shenghui D, Cao L, Kwok P-Y, Menter A, and Bowcock AM. Novel cluster of immunoglobulin superfamily members mapping to a region of 17q25.1 linked to psoriasis susceptibility. Hum. Genet. 112:34-41, 2002.

149. Zhou X, Krueger JG, Kao M-C, Lee E, Du F, Menter A, Wong WH, and Bowcock AM. Novel mechanisms of T-cell and dendritic cell activation revealed by profiling of psoriasis on the 63,100-element oligonucleotide array. Physiol. Genomics 13:69-78, 2003.

150. Haque WA, Oral EA, Dietz K, Bowcock AM, Agarwal AK, and Garg A. Risk factors for diabetes in familial partial lipodystrophy, Dunnigan variety. Diabetes Care 26:1350-1355, 2003.

151. Allen M, Barker JWN, Bowcock AM, Burden AD, Chia N, Capon F, Christophers E, Daly MJ, Elder JT, Helms C, Henseler T, Jenisch S, Menter A, Mistry R, Nair RP, Stuart PE, Tillman D, Trembath RC, Veal C, and Voorhees JJ. The international psoriasis genetics study: Assessing linkage to 14 candidate susceptibility loci in a 942 affected-sib-pair cohort. Am. J. Hum. Genet. 73:430-437, 2003.

152. Bowcock AM, and Barker JN. Genetics of psoriasis: The potential impact on new therapies. J. Am. Acad. Derm. 49:S51-56, 2003.

153. Helms C, Cao L, Krueger JG, Wijsman EM, Chamian F, Gordon D, Heffernan M, Daw J, Robarge J, Ott J, Kwok P-Y, Menter A and Bowcock AM. A putative RUNX1 binding site variant between SLC9A3R1 and NAT9 is associated with psoriasis susceptibility. Nat. Genet. 35:349-356, 2003.

154.Bowcock AM, and Cookson WO. The genetics of psoriasis, psoriatic arthritis and atopic dermatitis. Hum. Molec. Genet. 13:R43-R55, 2004.

155.Capon F, Helms C, Veal CD, Tillman D, Burden AD, Barker JN, Bowcock AM and Trembath RC. Genetic analysis of PSORS2 markers in a UK dataset supports the association between RAPTOR SNPs and familial psoriasis. J. Med. Genet. 41:459-460, 2004.

156. Suomela S, Cao L, Bowcock AM and Saarialho-Kere U. Interferon alpha-inducible protein 27 (IFI27) is up-regulated in psoriatic skin and certain epithelial cancers. J Invest Dermatol 122:717-721, 2004.

157. Gordon D, Hayes C, Jahnndis C, Bowcock AM, and Ott J. A transmission disequilibrium test for general pedigrees that is robust to the presence of random genotyping errors and any number of untyped parents. Eur. J. Hum. Genet. (in press), 2004.

158. Lew W, Bowcock AM, and Krueger JG. Psoriasis vulgaris: cutaneous lymphoid tissue supports T-cell activation and ‘Type 1' inflammatory gene expression. TRENDS in Immunology (in press), 2004.